Viewing Study NCT00097032


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-01-01 @ 1:54 PM
Study NCT ID: NCT00097032
Status: COMPLETED
Last Update Posted: 2011-05-24
First Post: 2004-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module